What Is the Average Weight Loss on Mounjaro Weekly?

Last reviewed: July 16, 2026

Last updated: July 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active compound in Mounjaro, demonstrated significant weight reduction in SURMOUNT clinical trials, with participants losing an average of 21% of their body weight at the highest dose. However, the weight loss you experience depends on your unique metabolic profile, adherence, and how your body responds to the medication. PlexusDx helps you understand your individual potential through genetic insights and affordable compounded tirzepatide therapy.

Clinical Trial Results for Tirzepatide Weight Loss

The SURMOUNT-1 trial enrolled 2,539 adults with obesity and compared tirzepatide to placebo over 68 weeks. Participants receiving the highest tirzepatide dose (15 mg weekly) achieved a mean weight loss of 22.5% of their baseline body weight, compared to 2.4% in the placebo group. At the intermediate dose (10 mg weekly), weight loss averaged 19.5%, and at the lowest dose (5 mg weekly), participants lost approximately 16% of their body weight on average.

Real-world outcomes often reflect trial data when patients maintain consistent dosing and combine medication with lifestyle modifications. The weight loss typically begins within the first 4 weeks and continues through 16 weeks of consistent treatment, with the most dramatic changes occurring between weeks 8 and 16. After 6 months of therapy, most individuals reach a plateau, though continued weight maintenance remains achievable with ongoing treatment.

Factors That Influence Your Individual Weight Loss on Tirzepatide

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, and FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Lifestyle factors including caloric intake, exercise frequency, sleep quality, and stress management directly impact medication effectiveness. Individuals who combine tirzepatide with structured nutrition and moderate physical activity typically achieve results closer to the upper end of clinical trial ranges. Starting dose, dose escalation tolerance, and how quickly your body adapts to appetite suppression also influence the timeline and magnitude of weight loss you experience.

How PlexusDx Tirzepatide Dosing Works for Maximum Results

PlexusDx offers compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, with the same quality standards as brand-name Mounjaro but at a lower cost. Your dose may need to go up as your body adapts and your provider adjusts therapy—but your price won't increase. This flat-rate pricing model removes barriers to dose optimization, ensuring you reach the most effective dose for your metabolic profile without financial penalty.

Most people begin at a low starter dose (typically 2.5 mg weekly) and titrate upward every 4 weeks until reaching their optimal therapeutic dose. Some individuals feel full effects at 5 mg weekly, while others benefit from advancing to 10 or 15 mg weekly. PlexusDx's optional Precision Peptide Genetic Test ($99 after your first month) can help your provider anticipate your personalized dose requirements based on your GIPR, GLP1R, and MC4R genetic variants.

Comparing Tirzepatide to Other GLP-1 Medications Available at PlexusDx

Tirzepatide activates two hormonal pathways—GLP-1 and GIP—making it a dual-agonist with greater appetite suppression potential than single-agonist semaglutide. Clinical evidence shows tirzepatide produces 4 to 6 percentage points more weight loss than semaglutide at equivalent time points, though individual response varies. PlexusDx offers both compounded semaglutide (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and tirzepatide (at $289/mo month-to-month, or from $249/mo on the 6-month plan), allowing your provider to select based on your genetic predispositions and tolerance profile.

For patients seeking an ultra-personalized approach, PlexusDx GLP-Squared Injection ($289/month) combines semaglutide and tirzepatide in a single compound to activate multiple peptide pathways simultaneously. All PlexusDx medications come from licensed 503A compounding pharmacies, are available in all 50 states without insurance, and are HSA/FSA eligible. Your provider can switch between formulations or doses without price changes, keeping affordability constant as your treatment evolves.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the average weight loss percentage on Mounjaro at the highest dose?

No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How long does it take to see weight loss results on tirzepatide?

Most people notice appetite reduction and initial weight loss within 2 to 4 weeks of starting tirzepatide. The most significant weight loss typically occurs between weeks 8 and 16 as your dose reaches therapeutic levels and your body adapts to the medication. Continuing treatment for 12 to 16 weeks generally produces results close to clinical trial outcomes.

Is PlexusDx compounded tirzepatide as effective as brand-name Mounjaro?

PlexusDx tirzepatide injections are compounded by licensed 503A pharmacies using the same active pharmaceutical ingredient and manufacturing standards as Mounjaro. Effectiveness depends on dose, consistency of use, and individual genetic factors—not the source of the compound. PlexusDx tirzepatide is $289 per month month-to-month, or from $249/mo on the 6-month plan flat, making it accessible without insurance while maintaining clinical equivalence.

What side effects might slow my weight loss or require dose adjustments?

Common tirzepatide side effects include mild nausea, vomiting, or constipation, which typically resolve within 1 to 2 weeks. Severe or persistent gastrointestinal symptoms may require a temporary dose pause or slower titration. Your PlexusDx provider can adjust your dosing schedule based on tolerance while keeping your monthly cost flat at $289, removing financial stress from dose management.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. PlexusDx Precision Peptide Genetic Test ($99 add-on after month one) identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation and metabolic response. These genetic insights across 14 pathways and 49 peptides help your provider estimate whether you may respond more robustly to tirzepatide or benefit from a dual-compound approach like GLP-Squared Injection.

Related Reading

• Average Weight Loss On Ozempic
• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.